Preparation of 99mTc-N2S2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 42, Issue 4, 1999, Pages 309-324

  Dezutter, Nancy A ^b   De Groot, Tjibbe J ^b   Busson, Roger H ^b   Janssen, Gerard A ^b   Verbruggen, Alfons M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

Alzheimer's disease; Beta amyloid; Chrysamine G; Diagnosis; Technetium 99m

Indexed keywords

ALKALINITY; CHLORINE COMPOUNDS; ESTERS; GLYCOPROTEINS; HYDROGENATION; ISOMERS; NEURODEGENERATIVE DISEASES; PROTEINS;

ALZHEIMERS DISEASE; BETA AMYLOID PROTEINS; BETA AMYLOIDS; CHRYSAMINE G; DIETHYL ESTER; ESTER DERIVATIVES; IN-VITRO; POTENTIAL PROBES; RP-HPLC; TECHNETIUM-99M;

DIAGNOSIS;

AMYLOID BETA PROTEIN; CHRYSAMINE G; DYE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; CONJUGATE; STAIN; SYNTHESIS;

EID: 0033026082     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1344(199904)42:4<309::AID-JLCR192>3.0.CO;2-O     Document Type: Article

References (27)

1. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., Taylor J.O. JAMA 262: 2551-2556 (1989)
2. Katzman R. Neurology 43: 13-20 (1993)
3. Joachim C.L., Morris J.H., Selkoe D.J. Ann. Neurol. 24: 50-56 (1988)
4. Khachaturian Z.S. Arch. Neurol. 42: 1097-1105 (1985)
5. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Neuron 13: 45-53 (1994)
6. Mori H., Takio K., Ogawara M., Selkoe D.J. J. Biol. Chem. 267: 17082-17086 (1992)
7. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., Beyreuther K. J. Mol. Biol. 218: 149-163 (1991)
8. Klunk W.E., Pettegrew J.W., Abraham D.J. J. Histochem. Cytochem. 37: 1273-1281 (1989)
9. Klunk W.E., Debnath M.L., Pettegrew J.W. Neurobiol. Aging 15: 691-698 (1994)
10. Klunk W.E., Debnath M.L., Pettegrew J.W. Neurobiol. Aging 16: 541-548 (1995)
11. Majocha R.E., Reno J.M., Friedland R.P., VanHaight C., Lyle L.R., Marotta C.A. J. Nucl. Med. 33: 2184-2189 (1992)
12. Friedland R.P., Majocha R.E., Reno J.M., Lyle L.R., Marotta C.A. Mol. Neurobiol. 9: 107-113 (1994)
13. Walker L.C., Price D.L., Voytko M.L., Schenk D.B. J. Neuropathol. Exp. Neurol. 53: 377-383 (1994)
14. Bickel U., Lee V.M.T., Trojanowski J.Q., Pardridge W.M. Bioconjugate Chem. 5: 119-125 (1994)
15. Kalaria R.N. Cerebrovasc. Brain Metab. Rev. 4: 226-260 (1992)
16. Han H., Cho C.-G., Lansbury P.T. J. Am. Chem. Soc. 118: 4506-4507 (1996)
17. Mathis C.A., Mahmood K., Debnath M.L., Klunk W.E. J. Labelled Cpd. Radiopharm. 40: 94-95 (1997)
18. Klunk W.E., Hamilton R.L., Styren S.D., Styren G., Debnath M.L., Mathis C.A., Mahmood K., Hsiao K.K. Soc. Neurosci. Abstr. 23: 1638 (1997)
19. Klunk W.E., Hamilton R.L., Styren S.D., Styren G., Debnath M.L. Soc. Neurosci. Abstr. 24: 264 (1998)
20. Kung H.F., Bradshaw J.E., Chumpradit S., Zhuang Z.-P., Kung M.-P., Mu M., Frederick D. In: Technetium and Rhenium in Chemistry and Nuclear Medicine 4, Nicolini M., Bandoli G., Mazzi U. (eds), SGEditoriali, Padova, 293-298, (1994)
21. Meegalla S.K., Plössl K., Kung M.-P., Chumpradit S., Stevenson D.A., Kushner S.A., McElgin W.T., Mozley P.D., Kung H.F. J. Med. Chem. 40: 9-17 (1997)
22. Oya S., Plössl K., Kung M.-P., Stevenson D.A., Kung H.F. Nucl. Med. Biol. 25: 135-140 (1998)
23. O'Neil J.P., Wilson S.R., Katzenellenbogen J.A. Inorg. Chem. 33: 319-323 (1994)
24. Pearson D.A., Blanchette M., Baker M.L., Guindon C.A. Tetrahedron Lett. 30: 2739-2742 (1989)
25. Yamauchi H., Takahashi J., Seri S., Kawashima H., Koike H. and Kato-Azuma M. In: Technetium and Rhenium in Chemistry and Nuclear Medicine 3, Nicolini M., Bandoli G., Mazzi U. (eds), Cortina International, Verona, 475-502 (1989)
26. Oldendorf W.H. Proc. Soc. Exp. Biol. Med. 147: 813-816 (1974)
27. Audus K.L., Chikhale P.J., Miller D.W., Thompson S.E., Borchardt R.T. In: Advances in drug research 23, Testa B. (ed), Academic Press, London, 1-64 (1992)